Clinical Trial Update: TUDCA as a Therapy for Ulcerative Colitis (UC) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating tauroursodeoxycholic acid (TUDCA) for Ulcerative Colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TUDCA (Tauroursodeoxycholic acid)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED